论文部分内容阅读
尽管有数种调脂药(LMD)治疗和调脂策略可用于成功地治疗具有心血管事件危险的患者,但是药物治疗的益处只有长期坚持应用才能体现。既往关于LMD停药率的观察研究并不能代表美国当前临床实践中的情
Although several lipid-lowering drug (LMD) treatment and lipid-lowering strategies can be successfully used to treat patients at risk of cardiovascular events, the benefits of drug therapy can only be demonstrated by long-term adherence. Past observations on LMD withdrawal rates do not represent the current state of clinical practice in the United States